Cancer research firm CG Oncology Inc., which has a novel treatment that’s been called a “game changer” for bladder cancer, is aiming for a $1 billion valuation when it goes public in the coming days.

Five months after reeling in $105 million from a pre-IPO crossover round, CG Oncology is now ready to take the plunge and go public. The company has yet to reveal an estimate for how much the shares ...

Bleach: Thousand-Year Blood War Part 3 – The Conflict was one of the many anime franchises taking the stage during Anime Expo 2024 this year, and it was here that fans got some special teases from the ...